INVOLVEMENT OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-BETA, INTERLEUKIN-8, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE LUNG INJURY CAUSED BY LOCAL SHWARTZMAN REACTION
Citation
S. Imamura et al., INVOLVEMENT OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-BETA, INTERLEUKIN-8, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE LUNG INJURY CAUSED BY LOCAL SHWARTZMAN REACTION, Pathology international, 47(1), 1997, pp. 16-24
Categorie Soggetti
Pathology
SICI code
1320-5463(1997)47:1<16:IOTII>2.0.ZU;2-A
Abstract
A local Shwartzman reaction (LSR) was prepared in rabbit lung as a mod
el of acute lung injury. To induce LSR, intratracheal injection of lip
opolysaccharide (LPS) 10 mu g into the lower lobe of the right lung, f
ollowed 24 h later by i.v. injection of LPS (10 mu g/kg). In the lung
with the LSR, myeloperoxidase activity, representing neutrophil accumu
lation, peaked at 1-2 h and was sustained for 48 h after challenge wit
h i.v. LPS. The lung water content peaked at 12 h, and decreased gradu
ally. Histological findings showed diffuse interstitial widening, intr
a-alveolar leukocyte infiltration with hemorrhage, and alveolar exudat
e formation. The production of tumor necrosis factor-alpha (TNF-alpha)
, interleukin-1 beta (IL-1 beta), interleukin-8 (IL-8), and IL-l recep
tor antagonist (IL-1Ra) in the lung was analyzed. TNF-alpha first elev
ated and peaked at 0.5 h (66.5 +/- 16.7 ng/g . lung), subsequently, IL
-1 beta and IL-8 increased and peaked at 2 h (17.8 +/- 3.4 ng/g . lung
and 336.9 +/- 49.6 ng/g . lung, respectively). IL-1Ra was present eve
n before the challenge, and the production increased to show a dual pe
ak (0.5 h, 1.5 +/- 0.2 mu g/g . lung; and 2 h, 1.6 +/- 0.1 mu g/g . lu
ng), and a large concentration of IL-l Ra was sustained for 48 h. Immu
nohistochemistry showed that the cellular source of these cytokines wa
s alveolar macrophages and infiltrating neutrophils. Thus, disclosing
the kinetics of the generation of cytokines led to a better understand
ing of their roles, namely TNF-alpha as an initiator, IL-l and IL-8 as
amplifier and effector, and IL-l Ra as regulator of the intensity of
acute inflammation.